Identification of novel pathways for drug development for lung disease

Details for Australian Patent Application No. 2008302076 (hide)

Owner The Trustees of Boston University The University Of Utah Research Foundation

Inventors Gustafson, Adam; Spira, Avrum; Bild, Andrea; Brody, Jerome S.

Agent Shelston IP

Pub. Number AU-A-2008302076

PCT Pub. Number WO2009/039457

Priority 60/994,643 19.09.07 US

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/039457 Priority application(s): WO2009/039457

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008302079-Co-administration of pimavanserin with other agents

2008302073-Electric vehicle network